2026 Global: Cold Plasma Market-Competitive Review (2032) report
Description
The 2026 Global: Cold Plasma Market-Competitive Review (2031) report features the global market size and projected growth/decline data for the period 2021 through 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for cold plasma market by geography and historical trend. The scope of the report extends to sizing of the cold plasma market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Plasmatreat GmbH is recognized as a leading provider of atmospheric cold plasma systems for industrial surface treatment and coating preparation, offering inline solutions that serve automotive, electronics, and manufacturing clients and commanding a significant market share in industrial applications. Adtec Plasma (Adtec Healthcare/Adtec Plasma Co., Ltd.) specializes in precision plasma equipment used across electronics, medical device cleaning, and surface modification, with strong penetration in Asian markets and a portfolio tailored to high-volume manufacturing. Nordson Corporation supplies integrated surface treatment platforms, leveraging extensive distribution networks to deliver plasma and corona systems for plastics and packaging industries while supporting global manufacturing customers. Neoplas med GmbH focuses on medical and healthcare plasma devices, developing clinical-grade cold plasma systems for wound care and sterilization that have featured prominently in recent regulatory approvals and strategic partnerships within the healthcare segment.
Apyx Medical (including Bovie Medical product lines) competes in surgical and wound-care plasma devices, expanding from electrosurgery heritage into cold plasma ablation and therapy with FDA clearances and device launches that strengthen its hospital sales channel. US Medical Innovations develops clinical cold plasma platforms for ablation and soft-tissue procedures, securing regulatory milestones that facilitate adoption in teaching hospitals and specialty clinics and positioning the company as a medical-market leader. Relyon Plasma GmbH (a TDK Electronics subsidiary) and Henniker Plasma supply compact and laboratory-to-production plasma systems, respectively, with Relyon emphasizing compact, process-optimized industrial units and Henniker targeting R&D and precision manufacturing customers. Enercon Industries Corporation and Europlasma N.V. address high-volume industrial needs—Enercon with corona and plasma treatment equipment for material handling and Europlasma with large-scale plasma systems for waste treatment and specialty industrial applications—supporting sectors from packaging to environmental processing.
Plasmacure B.V., Plasmacure and other emerging specialists concentrate on healthcare-focused cold plasma therapies for chronic wounds and antimicrobial treatments, attracting venture investment and strategic alliances to commercialize clinical platforms that claim accelerated healing and multi-drug-resistant infection control. Terraplasma medical GmbH and CINOGY System GmbH represent European device innovators offering both handheld and cart-based medical plasma systems tailored to dermatology, wound care, and sterilization workflows. Collectively these ten-plus major companies span industrial surface treatment, medical therapeutics, and environmental applications, differentiating by regulatory approvals, proprietary electrode and gas-mix technologies, SaaS-enabled dosing analytics, and channel strengths across manufacturing and clinical customers, driving competitive dynamics and continued market expansion.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for cold plasma market by geography and historical trend. The scope of the report extends to sizing of the cold plasma market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Plasmatreat GmbH is recognized as a leading provider of atmospheric cold plasma systems for industrial surface treatment and coating preparation, offering inline solutions that serve automotive, electronics, and manufacturing clients and commanding a significant market share in industrial applications. Adtec Plasma (Adtec Healthcare/Adtec Plasma Co., Ltd.) specializes in precision plasma equipment used across electronics, medical device cleaning, and surface modification, with strong penetration in Asian markets and a portfolio tailored to high-volume manufacturing. Nordson Corporation supplies integrated surface treatment platforms, leveraging extensive distribution networks to deliver plasma and corona systems for plastics and packaging industries while supporting global manufacturing customers. Neoplas med GmbH focuses on medical and healthcare plasma devices, developing clinical-grade cold plasma systems for wound care and sterilization that have featured prominently in recent regulatory approvals and strategic partnerships within the healthcare segment.
Apyx Medical (including Bovie Medical product lines) competes in surgical and wound-care plasma devices, expanding from electrosurgery heritage into cold plasma ablation and therapy with FDA clearances and device launches that strengthen its hospital sales channel. US Medical Innovations develops clinical cold plasma platforms for ablation and soft-tissue procedures, securing regulatory milestones that facilitate adoption in teaching hospitals and specialty clinics and positioning the company as a medical-market leader. Relyon Plasma GmbH (a TDK Electronics subsidiary) and Henniker Plasma supply compact and laboratory-to-production plasma systems, respectively, with Relyon emphasizing compact, process-optimized industrial units and Henniker targeting R&D and precision manufacturing customers. Enercon Industries Corporation and Europlasma N.V. address high-volume industrial needs—Enercon with corona and plasma treatment equipment for material handling and Europlasma with large-scale plasma systems for waste treatment and specialty industrial applications—supporting sectors from packaging to environmental processing.
Plasmacure B.V., Plasmacure and other emerging specialists concentrate on healthcare-focused cold plasma therapies for chronic wounds and antimicrobial treatments, attracting venture investment and strategic alliances to commercialize clinical platforms that claim accelerated healing and multi-drug-resistant infection control. Terraplasma medical GmbH and CINOGY System GmbH represent European device innovators offering both handheld and cart-based medical plasma systems tailored to dermatology, wound care, and sterilization workflows. Collectively these ten-plus major companies span industrial surface treatment, medical therapeutics, and environmental applications, differentiating by regulatory approvals, proprietary electrode and gas-mix technologies, SaaS-enabled dosing analytics, and channel strengths across manufacturing and clinical customers, driving competitive dynamics and continued market expansion.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
